Taking ibuprofen for COVID symptoms is not associated with worse outcomes, according to multiple large studies and meta-analyses conducted since the pandemic began. Early in 2020, a wave of alarm swept through social media and even official channels warning that ibuprofen could worsen COVID-19 infections, but the clinical evidence gathered since then has thoroughly contradicted that concern. The scare left a lasting impression, though, and many people still hesitate to reach for ibuprofen when they have a fever or body aches from COVID.
Where the Ibuprofen Scare Came From
In March 2020, France’s health minister publicly warned against using ibuprofen for COVID symptoms, recommending acetaminophen (paracetamol) instead. Around the same time, several scientists speculated that ibuprofen could be harmful. One concern, raised by a virology professor at the University of Reading, was that ibuprofen’s anti-inflammatory properties might “dampen down” the immune system and slow recovery. Another hypothesis suggested that ibuprofen could aggravate a key enzyme involved in regulating fluid balance in the lungs, potentially worsening the pneumonia seen in severe cases.1BMJ. Covid-19: ibuprofen should not be used for managing symptoms, say doctors and scientists
These warnings were based on theoretical reasoning and comparisons to the original SARS virus, not on clinical data from actual COVID patients. But the message spread fast. Within days, millions of people worldwide had heard some version of “don’t take ibuprofen if you have COVID.” The World Health Organization initially said it was looking into the matter before quickly clarifying that it did not recommend against ibuprofen. Still, the seed of doubt had been planted, and it proved stubbornly persistent even after evidence accumulated to the contrary.
What Large Studies Found
Since that initial panic, researchers have examined the question from multiple angles, and the findings have been remarkably consistent. A retrospective study of over 400 COVID patients at a medical center in Israel found no increased risk of death or need for breathing support among those who took ibuprofen compared to those who did not. Even among patients who used ibuprofen exclusively for fever, outcomes were no worse.2PubMed Central. Ibuprofen use and clinical outcomes in COVID-19 patients Mortality rates were nearly identical between the ibuprofen and non-ibuprofen groups, and the proportion needing respiratory support was essentially the same.
Larger studies reinforced this picture. A nationwide Danish cohort study found that filling an NSAID prescription in the month before testing positive for COVID was not linked to higher rates of death, hospitalization, ICU admission, mechanical ventilation, or kidney failure. A Saudi Arabian study reached the same conclusion for both acute and chronic NSAID users. And a U.S. multi-center study of over 1,300 COVID patients showed no connection between pre-admission NSAID use and kidney failure or death.3npj Primary Care Respiratory Medicine. The use of non-steroidal anti-inflammatory drugs (NSAIDs) in COVID-19
The strongest form of evidence on this question comes from systematic reviews and meta-analyses that pool data across many studies. One meta-analysis found that NSAID exposure in COVID-positive patients was not associated with excess risk of hospitalization, death, or severe outcomes. Looking specifically at ibuprofen, the pooled data showed no increased risk of death.4PubMed Central. NSAIDs and COVID-19: A Systematic Review and Meta-analysis A separate meta-analysis confirmed that NSAIDs including ibuprofen, aspirin, and COX-2 inhibitors were not significantly associated with higher risk of infection, ICU admission, mechanical ventilation, or need for supplemental oxygen.5eClinicalMedicine. Use of non-steroidal anti-inflammatory drugs and adverse outcomes during the COVID-19 pandemic: A systematic review and meta-analysis
The ACE2 Theory That Did Not Hold Up
The most scientifically specific version of the ibuprofen concern centered on a protein called ACE2, which the SARS-CoV-2 virus uses to enter human cells. The worry was that ibuprofen might increase levels of ACE2 on cell surfaces, essentially rolling out a welcome mat for the virus. If true, this would mean taking ibuprofen could make it easier for the virus to infect more cells and replicate faster.
Laboratory studies tested this directly and found it was not the case. When researchers exposed human cell lines to ibuprofen and other NSAIDs, the drugs did not affect ACE2 levels and did not change how easily the virus could enter cells or replicate. In one set of experiments, ibuprofen actually reduced viral replication at higher doses.6PubMed Central. Ibuprofen, other NSAIDs and COVID-19: a narrative review A systematic review looking across the available evidence found no direct interaction between ibuprofen and SARS-CoV-2, and no evidence that ibuprofen affects ACE2 regulation in human studies.7Consilium Medicum. Nonsteroidal anti-inflammatory drugs and ibuprofen for COVID-19: a systematic review
It is worth noting that some earlier studies hinting at harmful effects of NSAIDs on viral infection were done in lab dishes or animal models, not in people.8PubMed Central. NSAIDs in patients with viral infections, including Covid-19: Victims or perpetrators? One mouse study did find that NSAID treatment reduced the production of inflammatory signaling molecules and lowered neutralizing antibody levels during SARS-CoV-2 infection.9PubMed Central. Non-steroidal anti-inflammatory drugs dampen the cytokine and antibody response to SARS-CoV-2 infection But mouse immune systems respond differently from human ones, and the clinical data from thousands of actual COVID patients showed no translation of that effect into worse real-world outcomes. The gap between what happens in a mouse and what happens in a person is the central reason the early alarm was premature.
Ibuprofen Versus Acetaminophen
Many people switched from ibuprofen to acetaminophen (sold as Tylenol or paracetamol) in 2020 specifically because of COVID fears. But the head-to-head comparison does not support the idea that one is safer than the other for managing COVID symptoms. A nationwide Korean study that matched COVID patients who used acetaminophen against those who used NSAIDs found no significant differences in clinical outcomes between the two groups.10PubMed Central. Serious Clinical Outcomes of COVID-19 Related to Acetaminophen or NSAIDs from a Nationwide Population-Based Cohort Study The Israeli study mentioned earlier also found no differences in mortality or respiratory support needs between ibuprofen and paracetamol users.2PubMed Central. Ibuprofen use and clinical outcomes in COVID-19 patients
Both drugs are effective at bringing down fever and easing the aches that come with COVID. They work through different mechanisms: ibuprofen blocks prostaglandin production, which reduces both inflammation and pain,11PubMed Central. Non-steroidal anti-inflammatory drugs, prostaglandins, and COVID-19 while acetaminophen acts primarily in the brain to reduce fever and pain perception without much anti-inflammatory effect. For most people with mild to moderate COVID, the choice between the two comes down to personal preference and individual health considerations rather than any COVID-specific risk.
Standard Ibuprofen Risks Still Apply When You Are Sick
The fact that ibuprofen does not make COVID itself worse does not mean it is risk-free. Ibuprofen carries the same well-known side effects during a viral illness that it carries at any other time, and some of those risks can be more relevant when you are sick.
The biggest concern is kidney stress. When you have a fever, you tend to be dehydrated from sweating, reduced fluid intake, and sometimes vomiting or diarrhea. NSAIDs reduce blood flow to the kidneys, which is normally manageable in a well-hydrated person but can tip into trouble when fluid levels are already low. One large study of hospitalized children found that ibuprofen use was associated with a modestly higher risk of kidney injury, and the risk was dose-dependent and greater in children with pre-existing kidney problems or those in intensive care.12JAMA Network Open. Association of Ibuprofen Prescription With Acute Kidney Injury Among Hospitalized Children in China A separate commentary raised the point that COVID itself can stress the kidneys and cardiovascular system, and stacking NSAID use on top of that warrants caution in patients who are severely ill or already at risk for blood clots or renal problems.13PubMed Central. NSAIDs may increase the risk of thrombosis and acute renal failure in patients with COVID-19 infection
For someone managing mild COVID at home with a fever of 101°F and general misery, a standard dose of ibuprofen taken with food and plenty of fluids is not a meaningful danger. But if you are barely keeping fluids down, have kidney disease, are on blood thinners, or are sick enough to consider going to the hospital, acetaminophen may be the more conservative choice simply because it is gentler on the kidneys and stomach. That logic applies to any febrile illness, not just COVID.
What Regulatory Agencies Concluded
By mid-to-late 2020, the major international health authorities had weighed in. The WHO, the European Medicines Agency, and the U.S. FDA all concluded that there was no evidence linking NSAID use to a more severe course of COVID-19. Their guidance was that both paracetamol and NSAIDs including ibuprofen could be used to treat COVID symptoms like fever and pain, and that patients already taking NSAIDs for chronic conditions should not stop their medication out of COVID-related fear.7Consilium Medicum. Nonsteroidal anti-inflammatory drugs and ibuprofen for COVID-19: a systematic review That last point matters, because some people with arthritis or other inflammatory conditions abruptly stopped their prescribed NSAIDs in 2020, potentially causing flare-ups of their underlying disease for no good reason.
NSAIDs and COVID Vaccines
A related question that circulated alongside the ibuprofen debate was whether taking an NSAID before or after a COVID vaccine might weaken the immune response. The theoretical concern was the same: since NSAIDs tamp down inflammation, maybe they would also tamp down the immune activation that a vaccine is designed to provoke.
A pilot study that deeply profiled volunteers who did or did not take NSAIDs around the time of their COVID vaccinations found that the antibody response was intact regardless of NSAID use. Vaccine-specific antibodies and neutralizing activity were present in both groups.14Journal of Pharmacology and Experimental Therapeutics. Deep Phenotyping of Repeat SARS-CoV-2 Immunizations Concomitant with Nonsteroidal Anti-inflammatory Drug Consumption This was a small study and not the final word, but it lined up with the general clinical observation that people who took ibuprofen for post-vaccine soreness or fever did not show any sign of reduced vaccine effectiveness. Most health authorities said it was fine to take ibuprofen after vaccination if you needed it, though some suggested not pre-medicating routinely before the shot as a precaution.
Ibuprofen Use in Children With COVID
Parents were understandably anxious about this question, since ibuprofen is one of the two go-to medications (along with acetaminophen) for managing fever in children. Clinical guidelines aligned with the adult evidence. According to WHO recommendations and available clinical data, ibuprofen can be safely used for its fever-reducing and pain-relieving effects in children with COVID.15CHILD`S HEALTH. Safe use of ibuprofen in COVID-19 in children
The standard pediatric cautions still hold: dose by weight, not age; keep the child hydrated; and avoid ibuprofen in infants younger than six months. The kidney-stress concern mentioned earlier is relevant for any child who is significantly dehydrated or has an underlying kidney condition, but for a typically healthy child with a fever, ibuprofen remains a reasonable option.
NSAIDs and Long COVID
A newer and more tentative line of research has looked at whether NSAID use during acute COVID infection is connected to the risk of developing long COVID. A Korean nationwide cohort study found that patients who developed long COVID were somewhat more likely to have used NSAIDs in the first two weeks after diagnosis. However, when the researchers accounted for how long patients were in quarantine, a proxy for how sick they were, the association lost statistical significance. In other words, the people who took more NSAIDs early on were probably just sicker to begin with and therefore both more likely to reach for painkillers and more likely to develop lingering symptoms. During the later phase of illness, patients with long COVID actually used fewer NSAIDs than controls.16PLOS ONE. Association between long COVID and nonsteroidal anti-inflammatory drug use by patients with acute-phase COVID-19
This is a single observational study with the kind of confounding issues that make it impossible to draw causal conclusions. It does not suggest that ibuprofen causes long COVID. If anything, the finding that the link disappeared after adjusting for illness severity reinforces the same pattern seen throughout this research: NSAID use tracks with being sicker, but it does not appear to be what makes people sicker.
People Who Should Still Be Cautious
Even with all the reassuring COVID-specific data, ibuprofen is not appropriate for everyone. The groups who should think twice are the same groups who should always be cautious with NSAIDs, regardless of whether they have COVID:
- Kidney disease: NSAIDs reduce blood flow to the kidneys, and dehydration from fever or vomiting amplifies that effect. People with chronic kidney disease or anyone who is significantly dehydrated should opt for acetaminophen.
- Stomach ulcers or GI bleeding: Ibuprofen irritates the stomach lining. If you have a history of ulcers or take blood thinners, the risk of gastrointestinal bleeding goes up.
- Heart disease: Long-term NSAID use is associated with increased cardiovascular risk. A few days of standard-dose ibuprofen for a fever is different from chronic daily use, but people with serious heart conditions should check with their doctor.
- Third trimester of pregnancy: NSAIDs are generally avoided after 20 weeks of pregnancy because of potential effects on fetal kidney function and blood vessel development.
- Infants under six months: Ibuprofen is not recommended for very young babies. Acetaminophen is the standard choice for this age group.
For everyone else, the practical takeaway is straightforward. If you have COVID and feel lousy, ibuprofen is a reasonable choice for bringing down your fever and easing muscle pain. Drink enough fluids, stick to the recommended dose, and do not combine it with other NSAIDs like naproxen. If you prefer acetaminophen, that works too. The choice between the two is a matter of personal tolerance and pre-existing health conditions, not a COVID-specific safety decision. A prospective cohort study specifically examining chronic NSAID users with COVID found no greater risk of death in that group.17PubMed Central. Ibuprofen and NSAID Use in COVID-19 Infected Patients Is Not Associated with Worse Outcomes: A Prospective Cohort Study The 2020 scare, while understandable given how little we knew at the time, simply did not survive contact with real-world clinical data.